← Open Payments lookup

MARY GILLIS: Open Payments

NPI 1285082925 · COLUMBUS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$171 in 10 payments from 5 companies in 2025. Trend: 2023 $41 · 2024 $161 · 2025 $171

Food & beverage: $171
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$54
Novo Nordisk Inc3$47
Dexcom, Inc.2$36
Xeris Pharmaceuticals, Inc.1$20
Esperion Therapeutics, Inc.1$15

Products named: FARXIGA, Ozempic, Dexcom G6 Transmitter, GVOKE HYPOPEN, NEXLETOL.

Industry payments across MS — which companies pay providers there.